Related Experiment Video
Updated: Nov 4, 2025

07:46
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Published on: June 18, 2018
12.2K
Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease.
Jakub Surkont1, Stephen Joza1, Richard Camicioli1
1Division of Neurology, Department of Medicine, University of Alberta, Canada.
Parkinsonism & Related Disorders
|May 21, 2021
Summary
Parkinson's Disease (PD) is linked to brain microstructural changes in locomotion centers, particularly the thalamus and basal ganglia. Diffusion tensor imaging (DTI) reveals these changes correlate with specific gait impairments.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Gait impairments are a hallmark of Parkinson's Disease (PD), stemming from degeneration in crucial brain circuits.
- Diffusion tensor imaging (DTI) measures microstructural integrity (FA/MD) in brain tissues.
- Previous research suggests a link between brain circuit degeneration and motor deficits in PD.
Purpose of the Study:
- To investigate microstructural alterations in brain locomotion control centers in PD using DTI.
- To correlate DTI-derived measures with clinical and quantitative gait parameters in PD patients.
Main Methods:
- Recruited 21 PD patients with gait impairment and 15 controls.
- Conducted quantitative gait and clinical assessments in PD patients (medication ON/OFF).
- Performed Region of Interest (ROI) analysis on thalamus, basal ganglia, and mesencephalic locomotion centers (MLC) using DTI, examining FA and MD.
Main Results:
- Observed significant microstructural differences in the thalamus, caudate, and MLC in PD patients compared to controls.
- Thalamic DTI changes correlated with gait pace parameters (e.g., Timed Up and Go) in the medication ON state.
- Caudate DTI changes correlated with cadence and stride time in the medication OFF state.
Conclusions:
- PD is associated with distinct regional microstructural degradation in key locomotion control areas.
- DTI findings suggest a failure within the subcortical locomotion network in PD.
- DTI ROI analysis shows potential as a tool for assessing PD functional status and gait deficits, possibly serving as an imaging biomarker.
Related Concept Videos
Parkinson's Disease: Overview
1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Neural Regulation
40.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.8K
Parkinson's Disease: Treatment
623
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
623

